Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+5.44%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$45.5B
AUM Growth
+$4.5B
(+11%)
Cap. Flow
+$397M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
23.46%
Holding
3,358
New
566
Increased
1,087
Reduced
1,014
Closed
583
Top Buys
| 1 |
Amazon
AMZN
|
+$454M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$333M |
| 3 |
Eli Lilly
LLY
|
+$293M |
| 4 |
Costco
COST
|
+$290M |
| 5 |
Ford
F
|
+$274M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$374M |
| 3 |
Carrier Global
CARR
|
+$193M |
| 4 |
Fair Isaac
FICO
|
+$191M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$190M |
Sector Composition
| 1 | Technology | 22.49% |
| 2 | Consumer Discretionary | 14.95% |
| 3 | Financials | 10.21% |
| 4 | Healthcare | 10% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Vanguard Value ETF
VTV
$145B
| $827K | ﹤0.01% |
+4,678
| New | +$827K |
|
1627
Haleon
HLN
$43.9B
| $824K | ﹤0.01% |
79,468
-83,390
| -51% | -$865K |
|
1628
RadNet
RDNT
$5.69B
| $820K | ﹤0.01% |
14,405
-7,075
| -33% | -$403K |
|
1629
First Financial Bancorp
FFBC
$2.46B
| $817K | ﹤0.01% |
33,666
+22,748
| +208% | +$552K |
|
1630
Limoneira
LMNR
$275M
| $815K | ﹤0.01% |
52,108
+18,005
| +53% | +$282K |
|
1631
LendingClub
LC
$1.91B
| $814K | ﹤0.01% |
67,680
+15,898
| +31% | +$191K |
|
1632
Iron Mountain
IRM
$28.6B
| $814K | ﹤0.01% |
7,934
-57,780
| -88% | -$5.93M |
|
1633
Mitek Systems
MITK
$467M
| $814K | ﹤0.01% |
+82,193
| New | +$814K |
|
1634
Phibro Animal Health
PAHC
$1.61B
| $813K | ﹤0.01% |
+31,844
| New | +$813K |
|
1635
Nova
NVMI
$8.69B
| $813K | ﹤0.01% |
2,954
-3,296
| -53% | -$907K |
|
1636
Transcat
TRNS
$697M
| $812K | ﹤0.01% |
9,452
+6,362
| +206% | +$547K |
|
1637
Abeona Therapeutics
ABEO
$330M
| $806K | ﹤0.01% |
141,978
+104,037
| +274% | +$591K |
|
1638
Home Bancorp
HBCP
$433M
| $806K | ﹤0.01% |
+15,557
| New | +$806K |
|
1639
Monte Rosa Therapeutics
GLUE
$297M
| $803K | ﹤0.01% |
+178,136
| New | +$803K |
|
1640
Capitol Federal Financial
CFFN
$839M
| $803K | ﹤0.01% |
131,625
+932
| +0.7% | +$5.69K |
|
1641
Bridgewater Bancshares
BWB
$457M
| $802K | ﹤0.01% |
50,396
+32,398
| +180% | +$515K |
|
1642
Navient
NAVI
$1.28B
| $800K | ﹤0.01% |
56,744
+5,087
| +10% | +$71.7K |
|
1643
LoveSac
LOVE
$258M
| $799K | ﹤0.01% |
43,923
-27,556
| -39% | -$502K |
|
1644
Alnylam Pharmaceuticals
ALNY
$61.1B
| $798K | ﹤0.01% |
2,446
-3,822
| -61% | -$1.25M |
|
1645
DTE Energy
DTE
$28.4B
| $794K | ﹤0.01% |
5,995
+16
| +0.3% | +$2.12K |
|
1646
Omnicell
OMCL
$1.46B
| $792K | ﹤0.01% |
26,924
-134,174
| -83% | -$3.94M |
|
1647
Ambev
ABEV
$35.9B
| $791K | ﹤0.01% |
328,262
+262,941
| +403% | +$634K |
|
1648
Ultragenyx Pharmaceutical
RARE
$2.92B
| $788K | ﹤0.01% |
21,683
-198,201
| -90% | -$7.21M |
|
1649
Myriad Genetics
MYGN
$674M
| $788K | ﹤0.01% |
148,335
+68,208
| +85% | +$362K |
|
1650
WesBanco
WSBC
$3.03B
| $787K | ﹤0.01% |
24,871
-37,927
| -60% | -$1.2M |
|